GlobalData

CGRP antagonists drive growth, but access and reimbursement barriers remain challenges

There is a huge opportunity for developers and manufacturers to advance novel prophylactic and treatment options, says GlobalData

COPD diagnosed prevalent cases in 7MM set to increase, with significant age and regional variations, according to GlobalData

Real-world data show rVSV-ZEBOV vaccine is 84 per cent effective against Ebola, supporting its use in future outbreaks

The approval could present a major challenge to Ocaliva (obeticholic acid), which was until recently the sole approved drug for…

As obesity rates rise and trust in GLP-1R products grows, sales for drugs targeting this receptor are forecast to increase…

Biopharma sector sees market capitalisation rise to $4 trillion, driven by strong performances from Lilly, Novo Nordisk, and…

Benemae’s benaglutide injection (Feisumei) was the first innovator approved for obesity in July 2023 in China followed by Novo…

The lifesciences sector also reported 73 VC deals worth $2.5 billion

The study could be of high clinical value to cardiologists who are seeking an optimal treatment of choice for HF patients, which…